Johnson & Johnson against Novartis AG — live side-by-side technical comparison.
Prices as of 2026-11-11T15:52:45+00:00 UTC · updates daily
JNJ leads 6 of the 7 windows we measure — over 1 month JNJ is +5.4% and NVS +10.8%; over year to date JNJ is +34.4% and NVS +15.6%. The JNJ/NVS price ratio stands at 1.7383, below its 50-day average of 1.7908, and above the 200-day average of 1.6371. A ratio above its own average means JNJ is gaining on NVS; on this reading the recent edge belongs to NVS.
Compare JNJ and NVS: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| JNJ | NVS | |
|---|---|---|
| Price | $276.96 | $159.33 |
| 1 day | -1.4%lead | -2.4% |
| 5 days | +0.6%lead | -3.4% |
| 1 month | +5.4% | +10.8%lead |
| 6 months | +25.6%lead | +9.7% |
| Year to date | +34.4%lead | +15.6% |
| 1 year | +42.9%lead | +22.1% |
| 2 years | +78.6%lead | +50.8% |
| 52-week position | 93% of range | 76% of range |
| 52-week range | $193.07–$283.25 | $123.24–$170.46 |
| vs 50-day average | above $266.48 | above $149.21 |
| vs 200-day average | above $249.20 | above $152.44 |
| RSI (14) | 58 | 56 |
| Market cap | $675.9B | — |
| Analyst target | $279.41 (-0.5%) | — |
| Analysts | 22 | — |
| Consensus | Buy | — |
| Next earnings | Jan 26, 2027 | Oct 27, 2026 |
JNJ trades at $276.96, above its 50-day average of $266.48, and above the 200-day at $249.20. It sits at 93% of its 52-week range ($193.07–$283.25); 14-day RSI is 58, in neutral territory; an average session moves it about 2.6%. For levels, the first level overhead is $281.54 (1.6% away) and the first support below is $275.53 (0.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
NVS trades at $159.33, above its 50-day average of $149.21, and above the 200-day at $152.44. It sits at 76% of its 52-week range ($123.24–$170.46); 14-day RSI is 56, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $160.57 (0.8% away) and the first support below is $156.17 (2.0% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
JNJ is the more volatile of the two — an average session moves it 2.6% against 2.4% for NVS, so an identical position size carries roughly 1.1× the daily risk.
The comparison turns on those levels: JNJ clearing $281.54 or losing $275.53; NVS clearing $160.57 or losing $156.17. Until one of them gives way, the relative reading above stands.